Owing to a Publisher error Declaration/Conflict of Interest statements were not included in the published versions of the following articles, that appeared in previous issues of Clinical Parkinsonism & Related Disorders
The appropriate Declaration/Conflict of Interest statements, provided by the Authors, are included below.
-
1.
“The effect of GLP-1 receptor agonists in pre-clinical rodent models of Parkinson’s disease: A systematic review and meta-analysis” (Clinical Parkinsonism & Related Disorders Volume 6, 2022, 100133) https://doi.org/10.1016/j.prdoa.2022.100133
Conflict of Interest statement: The authors have no conflicts of interest to declare.
-
2.
“Associations between exercise classes and self-reported exercise by people with Parkinson’s disease at Parkinson’s foundation centers of excellence” (Clinical Parkinsonism & Related Disorders, Volume 6, 2022, 100137) https://doi.org/10.1016/j.prdoa.2022.100137
Conflict of Interest statement: Dr. Rafferty receives honorarium for the Parkinson’s Outcome Project Steering Committee and the Exercise Competency Work Group. No other authors have relevant COI.